Efficacy and Tolerability of Exenatide Once Weekly Over 6 Years in Patients with Type 2 Diabetes: An Uncontrolled Open-Label Extension of the DURATION-1 Study

Diabetes Technology& Therapeutics , Vol. 0, No. 0.

Source: Diabetes Technology - August 14, 2016 Category: Endocrinology Authors: Robert R. Henry Eric J. Klein Jenny Han Nayyar Iqbal Source Type: research